Skip to main content

GOLDMAN SACHS GROUP INC

Position in RVTY — Revvity, Inc.

CIK 886982 NEW YORK, NY

Position in RVTY

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$42,162,749
-$34,549,744 QoQ
Shares Held
481,255
-39.3% QoQ
Ownership
0.431%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 96.89852572960281.ToString("F0")% Shared 0.ToString("F0")% None 3.1014742703971905.ToString("F0")%

Common Shares in RVTY Over Time

Shares Held

Position Value (USD)

Derivatives in RVTY

reported options exposure · as of Mar 31, 2024
CallValue
$6,919,500
CallShares
65,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $5,861,764,434 across 35 Diagnostics & Research names. RVTY ranks #21 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RVTY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $42,162,749 481,255
2025-12-31 $76,712,493 792,894
2025-09-30 $42,628,400 486,348
2025-06-30 $71,460,797 738,842
2025-03-31 $64,231,602 607,104
2024-12-31 $46,567,374 417,233
2024-09-30 $47,979,449 375,573
2024-06-30 $43,088,441 410,914
2024-03-31 $33,440,085 318,477
2024-03-31 $6,919,500 65,900
2023-12-31 $45,453,283 415,820
2023-09-30 $28,859,045 260,696
2023-06-30 $34,769,356 292,696
2023-03-31 $45,962,305 344,907
2022-12-31 $41,052,347 292,771
2022-09-30 $50,519,226 419,839
2022-06-30 $80,788,781 568,055
2022-03-31 $161,995,181 928,552
2021-12-31 $382,207,217 1,900,961
2021-09-30 $271,513,370 1,566,815
2021-06-30 $218,258,534 1,413,500
2021-03-31 $153,440,610 1,196,045
2020-12-31 $227,197,809 1,583,260
2020-09-30 $199,576,461 1,590,124
2020-06-30 $105,554,548 1,076,099
2020-03-31 $58,359,012 775,226